Skip to main content
. 2020 Jul 3;7(5):2305–2317. doi: 10.1002/ehf2.12767

Figure 4.

Figure 4

Study hypothesis. DC percursors originate from CD34+ progenitor cells in the bone marrow. Following antigen contact, circulating DC precursors maturate and migrate to the site of inflammation, in this case the heart, unleashing myocardial inflammation through T‐cell activation. MCS‐18 treatment causes immune modulation and DC inhibition, resulting in milder inflammation.